Skip to main content

AngioDynamics, Inc.

corporate_fare Company Profile

AngioDynamics, Inc.

ANGO·NASDAQ·Industrial Applications And Services·CIK 0001275187

AngioDynamics, Inc. is a diversified medical technology company that designs, manufactures, and sells products and technologies to aid clinicians in treating patients with cardiovascular disease and cancer diagnoses. The company's strategy focuses on innovative research and development, expanding clinical and regulatory pathways, and customer-centric sales. AngioDynamics was founded in Queensbury, N.Y., U.S., in 1988 and began manufacturing and shipping products in the early 1990s. The company is headquartered in Latham, N.Y., with manufacturing primarily in Queensbury. Initially, it focused on products for interventional radiology, becoming known for diagnostic catheters for non-coronary angiography and thrombolytic delivery systems. Over the years, AngioDynamics grew through acquisitions, adding various product lines. Key acquisitions include RITA Medical Systems in January 2007, Oncobionic in May 2008, the assets of Diomed in June 2008, Vortex Medical, Inc. in October 2012, the assets of Microsulis Medical Limited in January 2013, and Clinical Devices in August 2013. These acquisitions brought in ablation and NanoKnife systems, vascular access products, angiographic products and accessories, dialysis products, drainage products, thrombolytic products, embolization products, and venous products. In September 2018, the company acquired RadiaDyne, which included endorectal and vaginal balloons. On October 2, 2019, AngioDynamics acquired Eximo Medical, Ltd. and its proprietary 355nm laser atherectomy technology (now Auryon) for Peripheral Artery Disease. On December 17, 2019, the company acquired the C3 Wave tip location asset from Medical Components Inc. On July 27, 2021, AngioDynamics acquired the Camaro Support Catheter asset from QX Medical, LLC. The company sold its Fluid Management business (acquired in May 2012) to Medline Industries, Inc. in May 2019 and the BioSentry product line (acquired in August 2018) to Merit Medical Systems, Inc. in June 2023.

AngioDynamics, Inc. (NASDAQ:ANGO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 20 items for ANGO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-14, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for ANGO spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Humana Medicare Advantage Coverage Expands NanoKnife IRE Access for Prostate and Liver Cancer
  • AngioDynamics Plunges 21% Despite Q1 Beat as AngioVac Weakness Spooks Investors
  • AngioDynamics Q1 FY2027: Revenue Up 6.9%, Gross Margin Expands 410 bps, Cash Burn Continues
  • AngioDynamics Q1 FY2027: Med Tech Growth Accelerates, Guidance Reiterated
  • AngioDynamics Names Eric Honroth CEO with $2.3M Signing Package; Clemmer Stays as $30K/Month Consultant

Financial Snapshot

Fiscal year ended May 31, 2026
Revenue
$320.17M
Net Income
-$36.74M
Diluted EPS
-$0.88
Op. Cash Flow
$3.09M
Free Cash Flow
$508K
Gross Profit
$174.89M
Operating Income
-$39.93M
Cash & Equivalents
$53.86M
Debt / Equity
0.00×
Net Margin
-11.5%
Shares Outstanding
41.7M sh
Source: 10-K · filed 2026-09-29 · accession 0001140361-26-037995

Short Interest & Short Volume

2.92 days to cover

FINRA reported short interest of 2,003,326 shares in ANGO as of the October 30, 2026 settlement, a 4.5% increase from the prior period — about 2.9 days to cover at its recent average daily volume. On November 20, 2026, 49.4% of ANGO volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,003,326 shares as of October 30, 2026
Change vs prior period▲ 4.5%
Days to cover2.92 at avg daily volume of 686,981
Daily short volume (FINRA facilities)49.4% of 117,371 shares on November 20, 2026
5-day average short volume40.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with A →
$10.8 -0.09% today
52-week range · as of 2026-10-08 $9.39 – $16.29
Market cap
$454.61M
Volume
430.8K (0.6× avg)
3-mo avg 674.2K
Live data · 2026-11-21 19:40 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ANGO - Latest Insights

ANGO
Oct 14, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $11.50
Real-time Price: $10.80 info
Change: -$0.700 (-6%) info
Market Cap: $454.609M info
ANGO
Oct 08, 2026, 1:44 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $11.55
Real-time Price: $10.80 info
Change: -$0.745 (-6%) info
Market Cap: $454.609M info
ANGO
Oct 08, 2026, 12:56 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.43
Real-time Price: $10.80 info
Change: -$0.630 (-6%) info
Market Cap: $454.609M info
ANGO
Oct 08, 2026, 7:17 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.90
Real-time Price: $10.80 info
Change: -$3.10 (-22%) info
Market Cap: $454.609M info
ANGO
Oct 08, 2026, 7:16 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $14.26
Real-time Price: $10.80 info
Change: -$3.46 (-24%) info
Market Cap: $454.609M info
ANGO
Oct 08, 2026, 6:13 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $14.04
Real-time Price: $10.80 info
Change: -$3.24 (-23%) info
Market Cap: $454.609M info
ANGO
Oct 08, 2026, 6:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $14.90
Real-time Price: $10.80 info
Change: -$4.10 (-28%) info
Market Cap: $454.609M info
ANGO
Jul 20, 2026, 7:21 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $13.51
Real-time Price: $10.80 info
Change: -$2.71 (-20%) info
Market Cap: $454.609M info
ANGO
Jul 14, 2026, 3:42 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $13.14
Real-time Price: $10.80 info
Change: -$2.34 (-18%) info
Market Cap: $454.609M info
ANGO
Jul 14, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.75
Real-time Price: $10.80 info
Change: -$2.95 (-21%) info
Market Cap: $454.609M info
ANGO
May 13, 2026, 9:06 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $10.84
Real-time Price: $10.80 info
Change: -$0.040 (-0.37%) info
Market Cap: $454.609M info
ANGO
Apr 23, 2026, 5:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $11.20
Real-time Price: $10.80 info
Change: -$0.400 (-4%) info
Market Cap: $454.609M info
ANGO
Apr 23, 2026, 4:59 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.20
Real-time Price: $10.80 info
Change: -$0.400 (-4%) info
Market Cap: $454.609M info
ANGO
Apr 02, 2026, 1:56 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.47
Real-time Price: $10.80 info
Change: +$0.330 (+3%) info
Market Cap: $454.609M info
ANGO
Apr 02, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.97
Real-time Price: $10.80 info
Change: -$1.17 (-10%) info
Market Cap: $454.609M info
ANGO
Apr 02, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $12.20
Real-time Price: $10.80 info
Change: -$1.40 (-11%) info
Market Cap: $454.609M info
ANGO
Feb 03, 2026, 5:20 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.43
Real-time Price: $10.80 info
Change: +$0.370 (+4%) info
Market Cap: $454.609M info
ANGO
Jan 14, 2026, 7:33 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.28
Real-time Price: $10.80 info
Change: +$0.523 (+5%) info
Market Cap: $454.609M info
ANGO
Jan 06, 2026, 3:19 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.84
Real-time Price: $10.80 info
Change: -$0.040 (-0.37%) info
Market Cap: $454.609M info
ANGO
Jan 06, 2026, 7:16 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.99
Real-time Price: $10.80 info
Change: -$3.19 (-23%) info
Market Cap: $454.609M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets